| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |